The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes
出版年份 2018 全文链接
标题
The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes
作者
关键词
-
出版物
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-04-27
DOI
10.1111/ajt.14895
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost Effectiveness of Pre– vs Post–Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals
- (2018) Sumeyye Samur et al. Clinical Gastroenterology and Hepatology
- Should we treat acute hepatitis C? A decision and cost-effectiveness analysis
- (2018) Emily D. Bethea et al. HEPATOLOGY
- Managing hepatitis C in patients with the complications of cirrhosis
- (2018) Marcus M. Mücke et al. LIVER INTERNATIONAL
- Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection
- (2018) Ulrich Spengler PHARMACOLOGY & THERAPEUTICS
- Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney
- (2018) Brittany A. Shelton et al. Transplant Infectious Disease
- Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
- (2018) Chiranjeevi Gadiparthi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States
- (2017) Aijaz Ahmed et al. HEPATOLOGY
- ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
- (2017) Luca S. Belli et al. JOURNAL OF HEPATOLOGY
- Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories
- (2017) M. Mendizabal et al. JOURNAL OF VIRAL HEPATITIS
- Expanding the use of hepatitis C–viremic kidney donors
- (2017) Deirdre Sawinski et al. KIDNEY INTERNATIONAL
- Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment
- (2017) Marcus M. Mücke et al. LIVER INTERNATIONAL
- Should all dialysis patients with hepatitis C be treated? If so, before or after kidney transplantation?
- (2017) Michel Jadoul et al. SEMINARS IN DIALYSIS
- State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
- (2017) Cecily A. Campbell et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
- (2017) Rakesh Aggarwal et al. PLoS One
- National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection
- (2016) D. A. Axelrod et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection
- (2016) Massimo Colombo et al. ANNALS OF INTERNAL MEDICINE
- Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Michelle C.M. Cheung et al. JOURNAL OF HEPATOLOGY
- New perspectives for preventing hepatitis C virus liver graft infection
- (2016) Daniel J Felmlee et al. LANCET INFECTIOUS DISEASES
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
- (2015) Soumitri Barua et al. ANNALS OF INTERNAL MEDICINE
- Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits
- (2015) Jayne Smith-Palmer et al. BMC INFECTIOUS DISEASES
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials
- (2015) Saleh A. Alqahtani et al. HEPATOLOGY
- Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
- (2015) K. Rajender Reddy et al. HEPATOLOGY
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
- (2015) Michael P. Curry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Hepatitis C Treatment and the Impact on Kidney Transplantation
- (2015) Deirdre Sawinski et al. TRANSPLANTATION
- A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation
- (2012) Gregory T. Everson et al. HEPATOLOGY
- Epidemiology, Surveillance, and Prevention of Hepatitis C Virus Infections in Hemodialysis Patients
- (2010) Priti R. Patel et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now